Literature DB >> 12523621

Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants.

Nicole Baumert1, Christof von Eiff, Franziska Schaaff, Georg Peters, Richard A Proctor, Hans-Georg Sahl.   

Abstract

Small colony variants (SCV) are slow-growing subpopulations with altered metabolism and reduced antibiotic susceptibility which, in the case of Staphylococcus aureus, can cause persisting and recurrent infections. We studied four SCVs and their corresponding parent strains: one clinical strain pair, one menaquinone-deficient spontaneous mutant, and two constructed mutants obtained by inactivation of hemB in S. aureus 8325-4 and COL, respectively. SCVs growing in chemically defined medium (CDM) with glucose limitation and enhanced buffering capacity were found to generate deltapsi of -120 to -140 mV, which is comparable to the parent strains. However, glucose is consumed inefficiently with small growth yields. In contrast to wild-type strains, deltapsi dropped immediately to values below -100 mV when glucose expired and other nutrients such as acetate and lactate did not allow for further growth. Accordingly, the sensitivity of SCVs toward antibiotics known to be taken up through deltapsi, such as aminoglycosides, dropped 10- to 30-fold when compared to the parent strain under routine MIC determination conditions. When growing in CDM, the susceptibility of SCVs varied according to the magnitude of deltapsi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12523621     DOI: 10.1089/10766290260469507

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  52 in total

1.  Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.

Authors:  Awele Maduka-Ezeh; Maria Teresa Seville; Shimon Kusne; Holenarasipur R Vikram; Janis E Blair; Kerryl Greenwood-Quaintance; Francisco Arabia; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.

Authors:  Christof von Eiff; Alexander W Friedrich; Karsten Becker; Georg Peters
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  sigmaB activity in a Staphylococcus aureus hemB mutant.

Authors:  Maria M Senn; Markus Bischoff; Christof von Eiff; Brigitte Berger-Bächi
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

4.  Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle.

Authors:  Indranil Chatterjee; Mathias Herrmann; Richard A Proctor; Georg Peters; Barbara C Kahl
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

5.  First case of febrile bacteremia due to a wild type and small-colony variant of Escherichia coli.

Authors:  D Tappe; H Claus; J Kern; A Marzinzig; M Frosch; M Abele-Horn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

6.  Insights into the mode of action of chitosan as an antibacterial compound.

Authors:  Dina Raafat; Kristine von Bargen; Albert Haas; Hans-Georg Sahl
Journal:  Appl Environ Microbiol       Date:  2008-05-02       Impact factor: 4.792

7.  Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype.

Authors:  Marina Wu; Christof von Eiff; Nahed Al Laham; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

8.  Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.

Authors:  Hoang Anh Nguyen; Olivier Denis; Anne Vergison; Anne Theunis; Paul M Tulkens; Marc J Struelens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

9.  Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus.

Authors:  John D Perry; Claire Rennison; Lynne A Butterworth; Andrew L J Hopley; F Kate Gould
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus.

Authors:  Christian Kohler; Christof von Eiff; Manuel Liebeke; Peter J McNamara; Michael Lalk; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.